104 related articles for article (PubMed ID: 9197894)
1. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study.
Bassaw K; Gangar K
Br J Obstet Gynaecol; 1997 Jun; 104(6):758-9. PubMed ID: 9197894
[No Abstract] [Full Text] [Related]
2. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study.
Ikomi AA; Singer A
Br J Obstet Gynaecol; 1997 Mar; 104(3):385-6. PubMed ID: 9091025
[No Abstract] [Full Text] [Related]
3. Response of "benign" metastasizing leiomyoma to progestin withdrawal. Case report.
Cohen JD; Robins HI
Eur J Gynaecol Oncol; 1993; 14(1):44-5. PubMed ID: 8472731
[TBL] [Abstract][Full Text] [Related]
4. A double-blind randomised controlled trial of the effects of medroxyprogesterone acetate on bone density of women taking oestrogen replacement therapy.
Mackey R
Br J Obstet Gynaecol; 1997 Aug; 104(8):973-4. PubMed ID: 9255101
[No Abstract] [Full Text] [Related]
5. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case--control study.
Lumbiganon P; Rugpao S; Phandhu-fung S; Laopaiboon M; Vudhikamraksa N; Werawatakul Y
Br J Obstet Gynaecol; 1996 Sep; 103(9):909-14. PubMed ID: 8813312
[TBL] [Abstract][Full Text] [Related]
6. Depo medroxyprogesterone acetate (DMPA) therapy for uterine myomata prior to surgery.
Johnson N; Fletcher H; Reid M
Int J Gynaecol Obstet; 2004 May; 85(2):174-6. PubMed ID: 15099785
[No Abstract] [Full Text] [Related]
7. Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception.
Cundy T; Cornish J; Roberts H; Reid IR
Am J Obstet Gynecol; 2002 May; 186(5):978-83. PubMed ID: 12015524
[TBL] [Abstract][Full Text] [Related]
8. Long-acting progestins--promise and prospects.
Popul Rep K; 1983 May; 11(2):K17-55. PubMed ID: 6222930
[No Abstract] [Full Text] [Related]
9. Treatment of endometriosis with depot medroxyprogesterone acetate: a preliminary experience.
Arowojolu AO
Afr J Med Med Sci; 2000 Mar; 29(1):55-8. PubMed ID: 11379470
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of uterine leiomyoma with depot leuprorelin acetate (Enantone-Gyn monthly depot). Effect on leiomyoma volume and operability. German Leuprorelin Study Group].
Stolz W; Pfützenreuter N
Zentralbl Gynakol; 1997; 119(10):468-75. PubMed ID: 9432825
[TBL] [Abstract][Full Text] [Related]
11. The effect of medroxyprogesterone acetate and heparin in the prevention of postsurgical adhesion formation in the rat uterine model.
Sağol S; Ozşener S; Dinçer O; Yilmaz H; Karadadas N
J Obstet Gynaecol Res; 1999 Aug; 25(4):287-93. PubMed ID: 10540534
[TBL] [Abstract][Full Text] [Related]
12. [Adjuvant therapy in uterine myoma].
Vikhliaeva EM
Vestn Ross Akad Med Nauk; 1997; (2):16-20. PubMed ID: 9376721
[TBL] [Abstract][Full Text] [Related]
13. WHO statement on hormonal contraception and bone health.
d'Arcangues C
Contraception; 2006 May; 73(5):443-4. PubMed ID: 16627029
[No Abstract] [Full Text] [Related]
14. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
[TBL] [Abstract][Full Text] [Related]
15. Premenopausal ovariectomy-related bone loss: a randomized, double-blind, one-year trial of conjugated estrogen or medroxyprogesterone acetate.
Prior JC; Vigna YM; Wark JD; Eyre DR; Lentle BC; Li DK; Ebeling PR; Atley L
J Bone Miner Res; 1997 Nov; 12(11):1851-63. PubMed ID: 9383690
[TBL] [Abstract][Full Text] [Related]
16. High-dose medroxyprogesterone acetate for the treatment of dysfunctional uterine bleeding in 24 adolescents.
Aksu F; Madazli R; Budak E; Cepni I; Benian A
Aust N Z J Obstet Gynaecol; 1997 May; 37(2):228-31. PubMed ID: 9222474
[TBL] [Abstract][Full Text] [Related]
17. Medroxyprogesterone acetate-induced secondary adrenal insufficiency.
Dux S; Bishara J; Marom D; Blum I; Pitlik S
Ann Pharmacother; 1998 Jan; 32(1):134. PubMed ID: 9475840
[No Abstract] [Full Text] [Related]
18. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report.
Harkins GJ; Davis GD; Dettori J; Hibbert ML; Hoyt RA
J Reprod Med; 1999 Mar; 44(3):309-12. PubMed ID: 10202754
[TBL] [Abstract][Full Text] [Related]
19. DMPA and BMD.
Parry R; Mansour D
J Fam Plann Reprod Health Care; 2006 Jan; 32(1):53. PubMed ID: 16492349
[No Abstract] [Full Text] [Related]
20. Contrasting effects of two hormone replacement therapies on the cardiovascular and mammary gland outcomes in surgically postmenopausal monkeys.
Suparto IH; Williams JK; Cline JM; Anthony MS; Fox JL
Am J Obstet Gynecol; 2003 May; 188(5):1132-40. PubMed ID: 12748457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
